Chevy Chase Trust Holdings, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Chevy Chase Trust Holdings, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$31,713,437
-20.1%
1,002,955
+3.0%
0.12%
-16.1%
Q2 2023$39,701,081
+13.7%
973,543
+3.9%
0.15%
+8.0%
Q1 2023$34,924,450
+3.0%
937,066
-3.6%
0.14%
-4.2%
Q4 2022$33,915,732
-46.7%
972,076
-14.5%
0.14%
-47.1%
Q3 2022$63,654,000
+18.7%
1,137,475
+9.8%
0.27%
+22.5%
Q2 2022$53,639,000
-30.2%
1,036,305
-1.9%
0.22%
-16.2%
Q1 2022$76,795,000
-42.9%
1,056,768
-7.1%
0.26%
-38.9%
Q4 2021$134,567,000
-13.4%
1,138,104
-1.8%
0.43%
-19.9%
Q3 2021$155,445,000
-23.0%
1,158,732
-7.0%
0.54%
-21.1%
Q2 2021$201,832,000
+89.9%
1,246,571
-5.9%
0.69%
+81.3%
Q1 2021$106,292,000
+19.4%
1,324,429
-19.0%
0.38%
+19.6%
Q4 2020$88,993,000
+148.1%
1,635,872
-9.3%
0.32%
+123.2%
Q3 2020$35,876,000
+9.5%
1,804,256
+15.8%
0.14%
+6.8%
Q2 2020$32,753,000
+93.4%
1,558,163
+12.5%
0.13%
+68.4%
Q1 2020$16,935,000
-13.4%
1,384,812
+3.9%
0.08%
+6.8%
Q4 2019$19,554,000
+16.7%
1,332,825
+6.2%
0.07%
+7.2%
Q3 2019$16,750,000
-7.0%
1,254,767
+14.1%
0.07%
-8.0%
Q2 2019$18,005,000
+22.4%
1,099,845
+15.0%
0.08%
+23.0%
Q1 2019$14,715,000
+55.0%
956,511
+37.6%
0.06%
+32.6%
Q4 2018$9,492,000
-55.3%
695,336
-6.3%
0.05%
-47.7%
Q3 2018$21,237,000
+18.3%
742,024
+13.1%
0.09%
+12.8%
Q2 2018$17,945,000
+44.7%
655,882
+11.5%
0.08%
+41.8%
Q1 2018$12,404,000588,1680.06%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders